NCT03582137View on ClinicalTrials.gov

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

January 4, 2022

Study Completion Date

January 4, 2022

Conditions
Parkinson Disease
Interventions
DRUG

Cannabidiol

Subjects randomized to this arm will receive Cannabidiol Cannabis extract oral solution

OTHER

Placebo

Subjects randomized to this arm will receive Placebo

Trial Locations (1)

80045

University of Colorado hospital, Aurora

All Listed Sponsors
collaborator

Colorado Department of Public Health and Environment

OTHER_GOV

lead

University of Colorado, Denver

OTHER

NCT03582137 - A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease | Biotech Hunter | Biotech Hunter